Brain & Behavior Research Foundation Comments on FDA Approval of New Depression Treatment

By In The News
March 6, 2019 in The Headlines

Recommended Posts

In The News

Posted March 6, 2019

- Share

Posted March 6, 2019

NEW YORK, March 6, 2019 /PRNewswire/ -- The Brain & Behavior Research Foundation (BBRF) applauds the FDA for its approval of Esketamine nasal spray as a new medication for treatment of resistant depression. Dr. Jeffrey Borenstein, a Manhattan psychiatrist and President & CEO of the Brain...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  222020
2. Jaydee
  17783
3. deicer
  13345
4. Kip Powick
  12311
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.4k
- Total Posts
  
  565k

Sign In

Brain & Behavior Research Foundation Comments on FDA Approval of New Depression Treatment

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support